tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Hyperlipidemias D006949 73 associated lipids
Melanoma D008545 69 associated lipids
Colitis D003092 69 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Weight Loss D015431 56 associated lipids
Parkinson Disease D010300 53 associated lipids
Nerve Degeneration D009410 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Precancerous Conditions D011230 48 associated lipids
Fatty Liver D005234 48 associated lipids
Psoriasis D011565 47 associated lipids
Leukemia P388 D007941 43 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypotension D007022 41 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Arthritis D001168 41 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Heart Failure D006333 36 associated lipids
Acne Vulgaris D000152 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Fever D005334 35 associated lipids
Glomerulonephritis D005921 35 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Burns D002056 34 associated lipids
Cataract D002386 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Uremia D014511 33 associated lipids
Memory Disorders D008569 33 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Stroke D020521 32 associated lipids
Diarrhea D003967 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Liver Diseases D008107 31 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis D003872 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Proteinuria D011507 30 associated lipids
Obesity D009765 29 associated lipids
Kidney Diseases D007674 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Brain Diseases D001927 27 associated lipids
Endotoxemia D019446 27 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Ascites D001201 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Cholestasis D002779 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Cystitis D003556 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Erythema D004890 22 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Ren H et al. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. 2013 Am. J. Nephrol. pmid:23343906
Ferreira A et al. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. 2017 Am. J. Nephrol. pmid:28511172
Tsipotis E et al. Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation: A Systematic Review and Meta-Analysis. 2016 Am. J. Nephrol. pmid:27576318
Issa N et al. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. 2013 Am. J. Nephrol. pmid:23796509
Li J et al. Evaluation of mycophenolic acid exposure using a limited sampling strategy in renal transplant recipients. 2013 Am. J. Nephrol. pmid:23689735
Lee CT et al. Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. 2011 Am. J. Nephrol. pmid:21691056
Soubhia RM et al. Tacrolimus and nonsteroidal anti-inflammatory drugs: an association to be avoided. 2005 Jul-Aug Am. J. Nephrol. pmid:15976495
El-Dahshan KF et al. Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. 2006 Am. J. Nephrol. pmid:16804292
von Felbert V et al. Squamous cell carcinoma arising from a localized vulval lesion of Hailey-Hailey disease after tacrolimus therapy. 2010 Am. J. Obstet. Gynecol. pmid:20816142
Kauppila S et al. The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus. 2010 Am. J. Obstet. Gynecol. pmid:19889396
Jensen JT et al. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study. 2004 Am. J. Obstet. Gynecol. pmid:15284791
Marquezan MC et al. Effect of Topical Tacrolimus in the Treatment of Thygeson's Superficial Punctate Keratitis. 2015 Am. J. Ophthalmol. pmid:26133248
Ciardella AP et al. Cytomegalovirus retinitis and FK 506. 2003 Am. J. Ophthalmol. pmid:12888078
Goldberg NR et al. Success with single-agent immunosuppression for multifocal choroidopathies. 2014 Am. J. Ophthalmol. pmid:25194229
Al-Amri AM Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. 2014 Am. J. Ophthalmol. pmid:24439439
Rikkers SM et al. Topical tacrolimus treatment of atopic eyelid disease. 2003 Am. J. Ophthalmol. pmid:12614745
Yen MT et al. Oscillopsia and pseudonystagmus in kidney transplant patients. 1999 Am. J. Ophthalmol. pmid:10612521
Mochizuki M et al. A clinical trial of FK506 in refractory uveitis. 1993 Am. J. Ophthalmol. pmid:7685147
Brazis PW et al. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. 2000 Am. J. Ophthalmol. pmid:10764869
Jung JW et al. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease. 2015 Am. J. Ophthalmol. pmid:25498356
Ishioka M et al. FK506 treatment of noninfectious uveitis. 1994 Am. J. Ophthalmol. pmid:7526689
Lee YJ et al. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases. 2013 Am. J. Ophthalmol. pmid:23394907
Moriya K et al. Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells. 2009 Am. J. Pathol. pmid:19729476
Lin Y et al. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. 2014 Am. J. Pathol. pmid:24269558
Maurer M et al. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. 1997 Am. J. Pathol. pmid:9094998
Bröcker V et al. Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance. 2012 Am. J. Pathol. pmid:22464889
Zager RA et al. Renal cholesterol accumulation: a durable response after acute and subacute renal insults. 2001 Am. J. Pathol. pmid:11485932
Lunz JG et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. 2001 Am. J. Pathol. pmid:11290556
Sohn HW et al. Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells. 1998 Am. J. Pathol. pmid:9846983
Langer A et al. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. 1993 Am. J. Pathol. pmid:7686346
Ito T et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. 2004 Am. J. Pathol. pmid:14742267
Rokaw MD et al. FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells. 1996 Am. J. Physiol. pmid:8760046
Tumlin JA et al. Expression of calcineurin activity and alpha-subunit isoforms in specific segments of the rat nephron. 1995 Am. J. Physiol. pmid:7485542
duBell WH et al. Independent inhibition of calcineurin and K+ currents by the immunosuppressant FK-506 in rat ventricle. 1998 Am. J. Physiol. pmid:9843803
Aoki Y et al. CsA-sensitive purine-box transcriptional regulator in bronchial epithelial cells contains NF45, NF90, and Ku. 1998 Am. J. Physiol. pmid:9843854
Kanoh S et al. Effect of FK506 on ATP-induced intracellular calcium oscillations in cow tracheal epithelium. 1999 Am. J. Physiol. pmid:10362712
Bragado MJ et al. p70s6k is activated by CCK in rat pancreatic acini. 1997 Am. J. Physiol. pmid:9252447
Shah AU et al. Protease activation during in vivo pancreatitis is dependent on calcineurin activation. 2009 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20501444
Yamada T et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11705744
Husain SZ et al. Caerulein-induced intracellular pancreatic zymogen activation is dependent on calcineurin. 2007 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17332472
Tashiro M et al. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:14684381
Gao G et al. Rapamycin inhibits hydrogen peroxide-induced loss of vascular contractility. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21357511
Fauconnier J et al. Frequency-dependent and proarrhythmogenic effects of FK-506 in rat ventricular cells. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15471978
Ogino A et al. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17644576
Balasubramaniam R et al. Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15923307
Giordano A et al. Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16428340
Kraiss LW et al. Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10775131
Kohno M et al. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12433661
Tang WX et al. Role of FKBP12.6 in cADPR-induced activation of reconstituted ryanodine receptors from arterial smooth muscle. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11893565
Gómez AM et al. FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes. 2004 Am. J. Physiol. Heart Circ. Physiol. pmid:15271664